It would be easier if CGB updated all shareholders as to what happened to the medcan deal rather than having shareholders constantly calling asking the same questions over and over.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025